Premium
Clinical trials during COVID ‐19
Author(s) -
Singh Arjun Gurmeet,
Chaturvedi Pankaj
Publication year - 2020
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26223
Subject(s) - covid-19 , pandemic , confusion , clinical trial , coronavirus , medicine , public relations , political science , psychology , outbreak , virology , disease , infectious disease (medical specialty) , pathology , psychoanalysis
As this ever‐evolving pandemic lays itself, more of its impact is being understood. Until recently, most guidelines were reported to aid in managing and treating suspected or confirmed cases. Research institutions around the world are responding with a sense of confusion. Some are continuing routinely, especially those who are overseeing clinical trials that could offer life‐saving therapies, particularly against the novel coronavirus. Since research must continue even in the face of a shutdown, we aim to collate the currently available recommendations from various organizations and provide guidance to head and neck researchers across the world during these trying times.